RetinalGenix Technologies Inc. (RTGN)
OTCMKTS · Delayed Price · Currency is USD
3.200
-0.350 (-9.86%)
At close: Nov 5, 2025
RetinalGenix Technologies Market Cap
RetinalGenix Technologies has a market cap or net worth of $59.54 million as of January 20, 2026.
Market Cap
59.54M
Enterprise Value
60.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.20
Market Cap Chart
Since February 24, 2022, RetinalGenix Technologies's market cap has increased from 42.85M to 59.54M, an increase of 38.95%. That is a compound annual growth rate of 9.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 59.54M | -37.25% |
| Dec 24, 2024 | 94.87M | 121.42% |
| Feb 24, 2022 | 42.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |